Novan, Inc.: Acne Vulgaris trials

The registry lists 13 Acne Vulgaris studies with Novan, Inc. as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 8Phase 2 3Phase 3 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• P3 Long Term Safety Study of Once Daily SB204 in AcneCompletedNCT02798120Phase 3Results posted
• P3 Study in Acne Comparing Once Daily SB204 and VehicleCompletedNCT02672332Phase 3Results posted
• P3 Study Comparing Once Daily SB204 and Vehicle Gel in AcneCompletedNCT02667444Phase 3Results posted
• P2 Multi-center Study of SB204 Gel in the Treatment of Acne VulgarisCompletedNCT02242760Phase 2Results posted
• Pharmacokinetics of Topical SB204 in Adolescents With Acne VulgarisCompletedNCT02801903Phase 1
• A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204CompletedNCT02581072Phase 1
• A Phase 1 Study Assessing Local Cutaneous Effects of SB204CompletedNCT02250430Phase 1
• A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne VulgarisCompletedNCT02164084Phase 1
• A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With AcneCompletedNCT01844752Phase 2
• A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 GelCompletedNCT01844739Phase 1
• A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy VolunteersCompletedNCT01755247Phase 1
• Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy VolunteersCompletedNCT01694810Phase 1
• Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01556698Phase 1/2